Quick answers
- What is Sodium phosphates used for?
- The FDA-approved label (Sodium Phosphates, Glenmark Pharmaceuticals Inc., USA, March 12, 2026) says: “Sodium phosphates injection, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Sodium phosphates have a boxed warning?
- No. None of the 2 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Sodium phosphates?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Sodium phosphates been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Sodium phosphates?
- 3 companies list prescription products of Sodium phosphates in the FDA NDC Directory, including Caplin Steriles Limited, Glenmark Pharmaceuticals Inc., USA and Amneal Pharmaceuticals Private Limited.
What Sodium phosphates is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Sodium phosphates injection, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. …
— FDA label: Sodium Phosphates, Glenmark Pharmaceuticals Inc., USA, effective March 12, 2026. Read the full label on DailyMed →
The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 2 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution |
|---|---|
| Route | Intravenous |
| Prescription products | 7 in the FDA NDC Directory |
| Brand names | Sodium Phosphates |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Caplin Steriles Limited3 products
- Glenmark Pharmaceuticals Inc., USA3 products
- Amneal Pharmaceuticals Private Limited1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (2)
- ANDA220683Caplin · February 23, 2026
- ANDA218274Amneal · October 15, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 1872384, 1872443, 1872447 |
|---|---|
| SPL set ID of the quoted label | c968f70b-a670-4aef-a7e0-89468ad62d9c |
| FDA labels (SPL) | 2 |
| FDA applications | 2 ANDA |
| Active ingredients (FDA) | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE / SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Sodium Phosphates, Glenmark Pharmaceuticals Inc., USA, effective March 12, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →